Ole Andreas Halvorsen, 10% Owner at Urovant Sciences Ltd. (UROV), bought 19,830 shares at $8.52 ($163K) on 2019-05-21, disclosed to the SEC on 2019-05-23.
Scheduled purchase ($163k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.52 | 9,995 | $85K | 52.2% |
| 2 | $8.06 | 5,033 | $41K | 24.9% |
| 3 | $7.76 | 4,802 | $37K | 22.9% |
| Total | $8.22 avg | 19,830 | $163K | 100% |
| Filing → |
| ZNTL | SELL | 2020-12-03 | $25.3M | — | Filing → |
| ADPT | SELL | 2020-01-30 | $245.4M | — | Filing → |
| UROV | BUY | 2019-06-19 | $262K | — | Filing → |